MarketCap
Facebook
X
TelegramAnnual report 2022
added 12-21-2024
Genetron Holdings Limited Cash Conversion Cycle 2011-2025 | GTH
Annual Cash Conversion Cycle Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 142 | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 142 | 142 | 142 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 20.5 | -4.92 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
299 | $ 0.23 | -2.26 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
83.5 | $ 230.58 | 0.1 % | $ 169 B | USA |
 |
DarioHealth Corp.
DRIO
|
207 | $ 10.56 | 5.18 % | $ 300 M |  Israel |
 |
BioNano Genomics
BNGO
|
225 | $ 1.5 | -1.07 % | $ 1.91 M | USA |
 |
Exact Sciences Corporation
EXAS
|
130 | $ 101.62 | 0.04 % | $ 18.8 B | USA |
 |
DexCom
DXCM
|
133 | $ 67.79 | 0.33 % | $ 26.2 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 26.61 | -0.41 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 19.02 | -2.36 % | $ 1.02 B | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.2 | - | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 226.58 | -0.15 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
49.1 | $ 101.62 | -1.32 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
45.1 | $ 6.35 | -2.08 % | $ 575 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-1.24 K | $ 4.81 | -5.39 % | $ 2.58 M | USA |
 |
Neogen Corporation
NEOG
|
150 | $ 7.2 | 0.91 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 18.82 | 0.83 % | $ 462 M | USA |
 |
Illumina
ILMN
|
142 | $ 133.99 | -0.71 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 203.2 | -0.17 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 175.29 | -0.38 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 6.8 | -0.29 % | $ 882 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.25 | 0.53 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 253.12 | -0.33 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
62 | $ 183.24 | 0.22 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
108 | $ 684.16 | -0.63 % | $ 56.4 B | USA |
 |
Personalis
PSNL
|
-11.5 | $ 8.02 | -1.47 % | $ 475 M | USA |
 |
Lantheus Holdings
LNTH
|
90.9 | $ 66.86 | 0.22 % | $ 4.63 B | USA |
 |
Quidel Corporation
QDEL
|
68.4 | $ 29.14 | -0.55 % | $ 1.23 B | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 415.25 | -0.36 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
111 | $ 138.08 | -0.22 % | $ 42 B | USA |
 |
RadNet
RDNT
|
34.9 | $ 73.09 | -0.08 % | $ 5.34 B | USA |